XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 770,997 $ 662,525
Marketable securities 352,021 520,144
Accounts receivable, net 582,855 508,532
Inventories 448,526 434,060
Prepaid expenses and other current assets 35,642 14,489
Deferred income taxes 0 35,439
Total current assets 2,190,041 2,175,189
Property, plant and equipment, net 3,230,523 3,004,067
Equity investments 8,929 9,208
Other assets, net    
Intangible assets, net 208,376 213,404
Deferred charges and other assets, net 282,695 167,417
Total other assets, net 491,071 380,821
Total assets 5,920,564 5,569,285
Current liabilities    
Accounts and notes payable 307,116 235,329
Accrued liabilities 312,985 287,313
Total current liabilities 620,101 522,642
Long-term debt, net 758,453 758,148
Deferred income taxes 664,987 575,603
Other liabilities 139,587 150,961
Total liabilities 2,183,128 2,007,354
Commitments and contingencies (Note 8 and 18)
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and 134,663,244 shares issued at June 30, 2016 and December 31, 2015, respectively 1,347 1,347
Common stock, held in treasury, at cost; 5,867,617 and 4,444,898 shares at June 30, 2016 and December 31, 2015, respectively (322,802) (258,312)
Additional paid-in capital 545,797 542,148
Retained earnings 3,296,922 3,109,987
Accumulated other comprehensive loss (82,101) (129,292)
Total Westlake Chemical Corporation stockholders' equity 3,439,163 3,265,878
Noncontrolling interests 298,273 296,053
Total equity 3,737,436 3,561,931
Total liabilities and equity $ 5,920,564 $ 5,569,285